Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 10Gastrointestinal 9Thoracic 6Head & Neck 3Genitourinary 3CNS 3Dermatologic 2Sarcoma 1Lymphoid 1Gynecologic 1

Conditions

Prostatic Neoplasms 3

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Diagnostic Imaging × Genitourinary × Clear all
NCT06866782 2025-03-11

RING

Fundacio Puigvert

Recruiting
600 enrolled
Genitourinary

Prostatic Neoplasms

NCT05228197 2025-01-22

IP6-CHAIROS

Imperial College London

Active not recruiting
750 enrolled
Genitourinary

Prostatic Neoplasms

NCT02177526 2015-11-18

Imaging of High Grade Prostate Cancer

Ottawa Hospital Research Institute

Phase NA Terminated
30 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡